- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02213965
Study Comparing the Handling of Two Peripheral IV Catheter Systems
January 21, 2019 updated by: B. Braun Melsungen AG
Clinical Investigation Acc. to MPG §23b: Open-label Prospective Study Comparing the Handling of the Handling of Two Peripheral IV Catheter (PIV) Systems (Ported and Non Ported) in Randomized Order
A peripheral intravenous catheter is the most commonly used vascular access device in medicine.
Primary objective is to compare insertion and handling of two peripheral intravenous catheters in clinical routine.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
2340
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 13353
- Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin CVK/CCM, Charité-Universitätsmedizin Berlin
-
Tübingen, Germany
- Universitätsklinik für Anästhesiologie und Intensivmedizin Tübingen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adults and children
Description
Inclusion:
- Patients of the center Anesthesiology, Operating-Room Management and Intensive Care Medicine, Gynaecology and Paediatrics in need for peripheral intravenous access
- Male and female patients, adult and paediatric
- Is able to give written informed consent, for children the legal representatives
Exclusion:
- Participation in another intervention trial during the study
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- The potential insertion site shows deformities, phlebitis, infiltration, dermatitis, burns, lesions, nerve injuries with paresthesia or tattoos
- Study PIV catheter site will be placed below an old infusion site
- Patient has a documented or known allergy sensitivity to a medical adhesive product such as transparent film, adhesive dressing, tapes or liquid skin protectants
- Patient requires the application of a topical ointment, or solution under the dressing in addition to the prep required in the protocol
- Patient has or had previous IV catheter-related phlebitis or infiltration during this hospitalization
- Patients with fear of injection
- Preterm infants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Vasofix® Safety
Peripheral IV catheter Vasofix® Safety
|
Intravenous access according to Instructions For Use
|
Introcan Safety®
Peripheral IV catheter Introcan Safety® IV catheter
|
Intravenous access according to Instructions For Use
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of successful puncturing on the first attempt
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of insertion failures
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Rate of difficulties to insert catheter and to withdraw the needle with regard to:Penetration characteristics of the needle, insertion and movement of catheter
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Rate and number of testing of ease of moving
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Rate and number of recannulation
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Rate, number and kind/extend of blood emission
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Incidence of needle stick injuries
Time Frame: During catheter fixation
|
During catheter fixation
|
|
Condition of fixation after completion of catheter insertion
Time Frame: During catheter fixation until directly after catheter insertion
|
dry and clean, moisturized, soiled?
|
During catheter fixation until directly after catheter insertion
|
Rate of adherence to standard application requirements of catheter placement
Time Frame: During catheter fixation until directly after catheter fixation
|
During catheter fixation until directly after catheter fixation
|
|
For Vasofix Safety: Rate and nature of use of application port
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
General judgment of catheter (school class grading)
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Adverse Events
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age and gender of the patient
Time Frame: At the beginning of the investigation
|
At the beginning of the investigation
|
|
ASA score of the patient
Time Frame: At the beginning of the investigation
|
At the beginning of the investigation
|
|
Weight and height of the patient
Time Frame: At the beginning of the investigation
|
At the beginning of the investigation
|
|
Vein and skin condition of the patient
Time Frame: At the beginning of the investigation
|
At the beginning of the investigation
|
|
Location of Peripheral Intervenous Catheter
Time Frame: After catheter fixation
|
After catheter fixation
|
|
Judgment on application port and wings given by user
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
|
|
Working experience of the user
Time Frame: At the beginning of the investigation
|
Working experience of the user in a hospital in at the beginning of the investigation
|
At the beginning of the investigation
|
Function of the user
Time Frame: At the beginning of the investigation
|
Job title of the user
|
At the beginning of the investigation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Claudia Spies, Univ.- Prof. Dr., Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin CVK/CCM, Charité-Universitätsmedizin Berlin
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
July 22, 2014
First Submitted That Met QC Criteria
August 8, 2014
First Posted (Estimate)
August 12, 2014
Study Record Updates
Last Update Posted (Actual)
January 23, 2019
Last Update Submitted That Met QC Criteria
January 21, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- HC-O-H 1411
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intravenous Access According to Instructions For Use
-
Physeon GmbHRegulatory Clinical Research Institute (RCRI)TerminatedDifficult-to-access Veins for Intravenous CannulationUnited States
-
B. Braun Melsungen AGCompleted
-
Medtronic Bakken Research CenterMedtronic GmbH GermanyCompletedPatients With an Indication for an ICD Implantation According to the Guidelines
-
Medtronic Cardiac Rhythm and Heart FailureCompletedClass I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National GuidelinesUnited States, Netherlands, Japan, Serbia, Spain, Greece, Canada, India, Denmark, Czechia, South Africa, Malaysia, Austria, United Kingdom, Hungary, China, Australia, France, Italy
-
University Hospital, Strasbourg, FranceTerminatedDiagnosis of Lupus According to ACR criteriaAgreement for the Blood SamplingFrance
-
Tunisian Association for Immuno-oncology ResearchNot yet recruitingIdentify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
-
University Hospital of PatrasNot yet recruitingStudy Focuses on the Use of Covered Stents (Stent Grafts) for the Treatment of Dysfunctional Vascular Access of Hemodialysis Patients
-
University of California, BerkeleyProcter and GambleUnknownConsumer Willingness to Pay for POU Products | Consumer Preferences and Use of POU ProductsKenya
-
Women's College HospitalCompleted
-
Bambino Gesù Hospital and Research InstituteCompletedSevere Pediatric Obesity (BMI > 97° pc -According to Centers for Disease Control and Prevention BMI Charts-) | Altered Liver Function Tests | Glycemic IntoleranceItaly
Clinical Trials on Peripheral IV catheter
-
Boston Medical CenterBard Peripheral Vascular, Inc.; Society for Academic Emergency MedicineTerminatedUltrasound Therapy; Complications | Vascular Access ComplicationUnited States
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
Universitaire Ziekenhuizen KU LeuvenBEDAL; RemedusTerminatedNeoplasms | Cystic Fibrosis | Pulmonary HypertensionBelgium
-
Optomeditech OyCardioMed Device Consultants, LLCTerminated
-
Smiths Medical, ASD, Inc.CompletedPeripheral Intravenous CatheterCanada
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
Smiths Medical, ASD, Inc.Completed
-
Eskisehir Osmangazi UniversityCompletedIntravenous CatheterizationTurkey
-
Wake Forest University Health SciencesWithdrawnPatient Satisfaction | Patient Preference
-
Optomeditech OyHospital District of Helsinki and Uusimaa; CardioMed Device Consultants, LLCTerminatedPeripheral Venous CatheterizationFinland